top of page
Recent Posts

Safety concerns raised for neuroblastoma candidate drug

  • OPACC
  • Nov 11, 2021
  • 1 min read

St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Then researchers identified safety concerns with the experimental drug that have implications for current clinical trials in adults.


Comments

Couldn’t Load Comments
It looks like there was a technical problem. Try reconnecting or refreshing the page.
Archive
Search By Tags
Rama logo.png
cgcg logo.jpg

524 Bayfield Street North
P.O. Box 20005
Barrie, ON L4M 5E9
Canada

info@opacc.org

705-828-7965

  • Wix Facebook page
  • Wix Twitter page
  • Instagram Social Icon
  • YouTube Social  Icon
bottom of page